Publications Archive

Author of over 20 peer-reviewed publications in lipidology, metabolic health, and cardiovascular risk

2025

Iqbal Z, Ferdousi M, Kalteniece A, Bashir B, et al.
Greater corneal nerve loss at inferior whorl in obesity.
Heliyon, 2025
DOI: 10.1016/j.heliyon.2025.e42627
ResearchGate: https://www.researchgate.net/publication/389034774_Greater_corneal_nerve_loss_at_inferior_whorl_in_obesity

2024

Iqbal Z, Vasan SK, Fachim H, Warner-Levy J, Donn RP, Ammori BJ, Heald AH, Soran H, Syed AA.
Are weight loss and metabolic outcomes of bariatric surgery influenced by candidate glucocorticoid receptor gene polymorphisms? A prospective study.
Adipocyte, 2024
https://pubmed.ncbi.nlm.nih.gov/38982594/

2023

Bashir B, Iqbal Z, Adam S, Ferdousi M, Chick W, Hussein HA, Syed AA, Le Roux CW, Cohen RV, Malik RA, Soran H.
Microvascular complications of obesity and diabetes: role of bariatric surgery.
Obesity Reviews, 2023
https://pubmed.ncbi.nlm.nih.gov/37436573/

Heald AH, Fachim HA, Bashir B, Garside B, Adam S, Iqbal Z, Syed AA, Donn R, Le Roux CW, Abdelaal M, White J, Soran H.
Impact of bariatric surgery on PCSK9 gene expression and inflammation in adipose tissue of obese diabetic rats.
International Journal of Molecular Sciences, 2023
https://pubmed.ncbi.nlm.nih.gov/38068435/

Bashir B, Iqbal Z, Schofield J, Soran H.
Lipids, atherosclerosis, and microvascular disease: Translating basic science into pharmacotherapeutics.
In: Cardiovascular Endocrinology and Metabolism, 2023
DOI: 10.1016/B978-0-323-99991-5.00012-7
ResearchGate: https://www.researchgate.net/publication/369726831_Lipids_atherosclerosis_and_microvascular_disease_Translating_basic_science_into_pharmacotherapeutics

2022

Iqbal Z, Bashir B, Adam S, et al.
Glycated apolipoprotein B decreases after bariatric surgery in people with and without diabetes: A potential contribution to reduction in cardiovascular risk.
Atherosclerosis, 2022
https://pubmed.ncbi.nlm.nih.gov/35331527/

Soran H, Adam S, Iqbal Z, Durrington P.
Mathematical modelling of the most effective goal of cholesterol-lowering treatment in primary prevention.
BMJ Open, 2022
https://pubmed.ncbi.nlm.nih.gov/35613766/

Adam S, Ho JH, Liu Y, Tarza Siahmansur, Siddals K, Iqbal Z, Azmi S, et al.
Bariatric Surgery-induced High-density Lipoprotein Functionality Enhancement Is Associated With Reduced Inflammation.
Journal of Clinical Endocrinology & Metabolism, 2022
https://pubmed.ncbi.nlm.nih.gov/35639942/

Adam S, Ho JH, Liu Y, et al.
Bariatric surgery leads to a reduction in antibodies to apolipoprotein A-1: a prospective cohort study.
Obesity Surgery, 2022
https://pubmed.ncbi.nlm.nih.gov/34888742/

Marouf BH, Iqbal Z, Mohamad JB, Bashir B, Schofield J, Syed A, Kilpatrick ES, Stefanutti C, Soran H.
Efficacy and safety of PCSK9 monoclonal antibodies in patients with diabetes.
Clinical Therapeutics, 2022
https://pubmed.ncbi.nlm.nih.gov/35246337/

D’Onofrio L, Ferdousi M, Kalteniece A, Iqbal Z, Petropoulos IN, Ponirakis G, Buzzetti R, Malik RA, Soran H.
Corneal confocal microscopy identifies small fibre damage in patients with hypertriglyceridaemia.
Journal of Clinical Lipidology, 2022
https://pubmed.ncbi.nlm.nih.gov/35562280/

2021

Iqbal Z, Bashir B, Ferdousi M, Kalteniece A, Alam U, Malik RA, Soran H.
Lipids and peripheral neuropathy.
Current Opinion in Lipidology, 2021
https://pubmed.ncbi.nlm.nih.gov/34101657/

Iqbal Z, Kalteniece A, Ferdousi M, Adam S, D’Onofrio L, Ho JH, Rao AP, Dhage S, Azmi S, Liu Y, Donn R.
Corneal keratocyte density and corneal nerves are reduced in patients with severe obesity and improve after bariatric surgery.
Investigative Ophthalmology & Visual Science, 2021
https://pubmed.ncbi.nlm.nih.gov/33475689/

Iqbal Z, Fachim HA, Gibson JM, Baricevic-Jones I, Campbell AE, Geary B, Donn RP, Hamarashid D, Syed A, Whetton AD, Soran H.
Changes in the proteome profile of people achieving remission of type 2 diabetes after bariatric surgery.
Journal of Clinical Medicine, 2021
https://pubmed.ncbi.nlm.nih.gov/34441734/

Fachim HA, Iqbal Z, Gibson JM, Baricevic-Jones I, Campbell AE, Geary B, Syed AA, Whetton A, Soran H, Donn RP, Heald AH.
Plasma proteome and inflammatory marker changes after bariatric surgery.
Cells, 2021
https://pubmed.ncbi.nlm.nih.gov/34685777/

Garside B, Ho JH, Liu Y, Dhage S, Donn R, Iqbal Z, Jones SA, Soran H.
Changes in PCSK9 and apolipoprotein B100 in Niemann–Pick disease after enzyme replacement therapy with olipudase alfa.
Orphanet Journal of Rare Diseases, 2021
https://pubmed.ncbi.nlm.nih.gov/34979862/

Adam S, Ho JH, Bashir B, Iqbal Z, Ferdousi M, Syed AA, Soran H.
Impact of cardiovascular disease, dyslipidaemia and lipid-lowering therapy on COVID-19 outcomes.
Current Opinion in Lipidology, 2021
https://pubmed.ncbi.nlm.nih.gov/34101658/

Adam S, Azmi S, Ho JH, Liu Y, Ferdousi M, Siahmansur T, Kalteniece A, Marshall A, Dhage SS, Iqbal Z, et al.
Improvements in diabetic neuropathy and nephropathy after bariatric surgery: a prospective cohort study.
Obesity Surgery, 2021
https://pubmed.ncbi.nlm.nih.gov/33104989/

Ho JH, Ong KL, Torres LF, Liu Y, Adam S, Iqbal Z, et al.
High density lipoprotein-associated miRNA is increased following Roux-en-Y gastric bypass surgery.
Journal of Lipid Research, 2021
https://pubmed.ncbi.nlm.nih.gov/33093236/

2020

Iqbal Z, Ho JH, Adam S, France M, Syed A, Neely D, Rees A, Khatib R, Cegla J, Byrne C, Qureshi N.
Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: an expert panel position statement from HEART UK.
Atherosclerosis, 2020
https://pubmed.ncbi.nlm.nih.gov/33045618/

Iqbal Z, Adam S, Ho JH, Syed AA, Ammori BJ, Malik RA, Soran H.
Metabolic and cardiovascular outcomes of bariatric surgery.
Current Opinion in Lipidology, 2020
https://pubmed.ncbi.nlm.nih.gov/32618731/

Soran H, France M, Adam S, Iqbal Z, Ho JH, Durrington PN.
Quantitative evaluation of statin effectiveness versus intolerance and strategies for management of intolerance.
Atherosclerosis, 2020
https://pubmed.ncbi.nlm.nih.gov/32683135/

Kwok S, Adam S, Ho JH, Iqbal Z, Turkington P, Razvi S, Le Roux CW, Soran H, Syed AA.
Obesity: a critical risk factor in the COVID‐19 pandemic.
Clinical Obesity, 2020
https://pubmed.ncbi.nlm.nih.gov/32857454/

2019

Iqbal Z, Dhage S, Mohamad JB, Abdel-Razik A, Donn R, Malik R, Ho JH, Liu Y, Adam S, Isa B, Stefanutti C, Soran H.
Efficacy and safety of PCSK9 monoclonal antibodies.
Expert Opinion on Drug Safety, 2019
https://pubmed.ncbi.nlm.nih.gov/31623472/

2018

Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, Lim J, Malik RA, Alam U.
Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy.
Clinical Therapeutics, 2018
https://pubmed.ncbi.nlm.nih.gov/29709457/

2016

Ball SG, Iqbal Z
Diagnosis and treatment of hyponatraemia.
Best Practice & Research Clinical Endocrinology & Metabolism, 2016
https://pubmed.ncbi.nlm.nih.gov/27156756/

2012

Iqbal Z, Michael BD, Pomeroy I, Ali R, Wilson M, Wieshmann U.
Multiple cranial neuropathies: one diagnostic difficulty.
Practical Neurology, 2012
https://pubmed.ncbi.nlm.nih.gov/22661354/